Phosphorylation of Focal Adhesion Vasodilator‐Stimulated Phosphoprotein at Ser157 in Intact Human Platelets Correlates with Fibrinogen Receptor Inhibition

FEBS Journal - Tập 225 Số 1 - Trang 21-27 - 1994
Karen Horstrup1, Bernd Jablonka2, Petra Hönig‐Liedl1, Melitta Just2, K. Kochsiek1, Ulrich Walter1
1Medizinische Universitätsklinik, Klinische Forschergruppe, Würzburg, Germany
2Cassella AG, Pharma Research, Frankfurt, Germany

Tóm tắt

Integrins and other adhesion receptors are essential components for outside‐in and inside‐out signaling through the cell membrane. The platelet glycoprotein IIb‐IIIa (also known as fibrinogen receptor or integrin αIIbβ3) is activated by platelet agonists, inhibited by cyclic‐nucleotide‐elevating agents, and is involved in the activation of protein tyrosine kinases including the 125‐kDa focal adhesion kinase (pp125FAK). However, the molecular details of glycoprotein IIb‐IIIa regulation are not well understood. Here we report that in ADP‐activated human platelets cAMP‐ and cGMP‐dependent protein‐kinase‐mediated phosphorylation of the focal adhesion vasodilator‐stimulated phosphoprotein (VASP) at Ser157 correlates well with glycoprotein IIb‐IIIa inhibition. Human platelets contain similar concentrations of glycoprotein IIb‐IIIa complexes (fibrinogen binding sites) and VASP. Using gel‐filtered platelets, cAMP‐elevating agents [e.g. prostaglandin E1 and the forskolin analog 6‐(3‐dimethylaminopropionyl)forskolin (NKH 477)] caused VASP Ser157 phosphorylation and inhibited glycoprotein IIb‐IIIa activation up to 70–100%. NO‐generating, cGMP‐elevating agents [e.g. 3‐morpholinosydnonimine hydrochloride (SIN1) and sodium nitroprusside] stimulated VASP Ser157 phosphorylation and inhibited glycoprotein IIb‐IIIa activation up to a maximal extent of 30–50%. The effects of cAMP‐ and cGMP‐elevating agents on VASP phosphorylation and fibrinogen binding were reversible and could be mimicked by membrane‐permeant selective activators of platelet cAMP‐ or cGMP‐dependent protein kinase, respectively. Using threshold concentrations, the nitrovasodilator SIN 1 potentiated the effects of the forskolin analog NKH 477 with respect to inhibition of platelet aggregation, VASP phosphorylation and glycoprotein IIb‐IIIa inhibition. It is proposed that the inhibition of glycoprotein IIb‐IIIa induced by cyclic nucleotide involves cAMP‐and cGMP‐dependent protein‐kinase‐mediated VASP phosphorylation at Ser157.

Từ khóa


Tài liệu tham khảo

10.1056/NEJM198410253111705

10.1056/NEJM199303043280907

10.1016/0092-8674(92)90115-S

10.1016/0955-0674(92)90100-Q

10.1101/SQB.1992.057.01.027

10.1016/0955-0674(92)90099-X

10.1055/s-0038-1646166

10.1055/s-0038-1646195

10.1083/jcb.119.4.905

10.1016/S0021-9258(18)82334-1

10.1083/jcb.122.2.473

10.1083/jcb.120.6.1501

Philipps D. R., 1980, J. Cell Biol., 86, 77, 10.1083/jcb.86.1.77

10.1002/jcb.240270309

10.1083/jcb.121.6.1329

10.1038/283195a0

10.1042/bj2730115

10.1016/S0021-9258(17)30619-1

Halbrügge M., 1993, Protein kinases in blood cell function, 245

10.1111/j.1432-1033.1989.tb15079.x

10.1016/S0021-9258(19)39737-6

10.1073/pnas.89.3.1031

10.1016/S0021-9258(19)38681-8

Torti U., 1994, Thromb. Haemostas., 71, 533, 10.1055/s-0038-1642478

10.1002/j.1460-2075.1992.tb05264.x

10.1016/S0021-9258(17)36652-8

Jablonka B., 1993, Endothelium, 1, S69, 10.3109/10623329309100959

10.1016/S0021-9258(18)50603-7

Benett J. S., 1979, J. Clin. Invest., 64, 1393, 10.1172/JCI109597

Just M., 1991, J. Cardiovasc. Pharmacol., 17, S121, 10.1097/00005344-199117003-00023

10.1016/0076-6879(92)15067-M

10.1111/j.1432-1033.1992.tb16803.x

10.1097/00005344-199204000-00021

10.1016/0006-2952(91)90711-D

10.1073/pnas.82.23.8057

Wencel‐Drake J. D., 1993, Blood, 81, 62

10.1016/S0021-9258(18)54042-4

10.1042/bj2790521

10.1016/0006-2952(92)90148-C

10.1161/01.CIR.66.6.1299

Maurice D. H., 1990, Mol. Pharmacol., 37, 671

Furman M. I., 1993, Thromb. Haemostas., 70, 229, 10.1055/s-0038-1646196

10.1016/S0021-9258(19)74482-2

10.1126/science.1439807

10.1083/jcb.124.6.1047